id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2023-D-2439-0011,FDA,FDA-2023-D-2439,QTc Information in Human Prescription Drug and Biological Product Labeling; Guidance for Industry,Other,Guidance,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,,2025-12-13T10:00:31Z,,1,0,09000064b90ab2ec
FDA-2023-D-2439-0010,FDA,FDA-2023-D-2439,QTc Information in Human Prescription Drug and Biological Product Labeling; Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,,2025-12-03T19:27:24Z,2025-21798,0,0,09000064b90abe6a